Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bivalirudin PCI Registry in HIT/HITTS Patients

NCT00759083 is registered in ClinicalTrials.gov with The Medicines Company as lead sponsor.

NCT NCT00759083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00759083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bivalirudin PCI Registry in HIT/HITTS Patients
Lead sponsor
The Medicines Company
Phase
Phase 4
Overall status
Withdrawn
Start date
September 30, 2008
Completion date
May 10, 2010
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heparin-induced thrombocytopenia, heparin-induced thrombocytopenia and thrombosis syndrome